Skip to content

NYSE · CIK 0001771910

ADCT ADC Therapeutics SA

Insider trading from SEC Form 4. Last filing Feb 14, 2025. Close $1.73 on Oct 9, 2026, +80% from the 52-week low and -65% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company

Price and insider trades, last year

ADCT, daily close, last year. insider buy insider sellDot size follows the dollar value (largest $609k).

Signals

Open-market buys and sells at ADC Therapeutics SA, scored.

ScoreSideInsiderValueSharesHoldings changePrice contextFiled
27WeakbuyRedmile Group, LLC
owner
$609k200,000+1%-
19WeaksellRedmile Group, LLC
owner
$52k25,352-0%-

Transactions

The last 21 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Feb 13, 2025Carmona Jose
Chief Financial Officer
AGrant or award
Common Shares
+240,000$1.61$386k541,892Feb 14, 2025
Feb 13, 2025Kallebo Lisa Michelle
Chief Accounting Officer
AGrant or award
Common Shares
+41,900$1.61$67k77,897Feb 14, 2025
Feb 13, 2025Zaki Mohamed
Chief Medical Officer
AGrant or award
Common Shares
+230,000$1.61$370k462,888Feb 14, 2025
Feb 13, 2025GRAHAM PETER J
Chief Legal Officer
AGrant or award
Common Shares
+220,000$1.61$354k408,542Feb 14, 2025
Feb 13, 2025MALLIK AMEET
Chief Executive Officer
AGrant or award
Common Shares
+650,000$1.61$1.0M1,579,005Feb 14, 2025
Dec 11, 2024Redmile Group, LLC
owner
POpen-market purchase
Common Shares, par value CHF 0.08 per shareindirect: See Footnotes
+50,000$2.28$114k15,616,731Dec 13, 2024
Dec 11, 2024Redmile Group, LLC
owner
POpen-market purchase
Common Shares, par value CHF 0.08 per shareindirect: See Footnotes
+50,000$3.81$191k15,666,731Dec 13, 2024
Dec 11, 2024Redmile Group, LLC
owner
POpen-market purchase
Common Shares, par value CHF 0.08 per share
+50,000$2.28$114k13,095,712Dec 13, 2024
Dec 11, 2024Redmile Group, LLC
owner
POpen-market purchase
Common Shares, par value CHF 0.08 per share
+50,000$3.81$191k13,145,712Dec 13, 2024
Dec 6, 2024GRAHAM PETER J
Chief Legal Officer
FTax withholding
Common Shares
-41,458$3.13$130k188,542Dec 9, 2024
Dec 6, 2024Zaki Mohamed
Chief Medical Officer
FTax withholding
Common Shares
-37,112$3.13$116k232,888Dec 9, 2024
Dec 6, 2024Kallebo Lisa Michelle
Chief Accounting Officer
FTax withholding
Common Shares
-6,503$3.13$20k35,997Dec 9, 2024
Dec 6, 2024Carmona Jose
Chief Financial Officer
FTax withholding
Common Shares
-48,108$3.13$151k301,892Dec 9, 2024
Dec 6, 2024MALLIK AMEET
Chief Executive Officer
FTax withholding
Common Shares
-238,343$3.13$746k929,005Dec 9, 2024
Dec 4, 2024Redmile Group, LLC
owner
SOpen-market sale
Common Shares, par value CHF 0.08 per shareindirect: See Footnotes
-25,352$2.07$52k15,566,731Dec 6, 2024
Dec 4, 2024Redmile Group, LLC
owner
JOther
Common Shares, par value CHF 0.08 per shareindirect: See Footnotes
-50,672$2.07$105k15,516,059Dec 6, 2024
Dec 4, 2024Redmile Group, LLC
owner
JOther
Common Shares, par value CHF 0.08 per shareindirect: See Footnotes
+50,672$2.07$105k15,566,731Dec 6, 2024
Dec 4, 2024Redmile Group, LLC
owner
JOther
Common Shares, par value CHF 0.08 per share
+50,672$2.07$105k13,045,712Dec 6, 2024
Dec 4, 2024Redmile Group, LLC
owner
JOther
Pre-Funded Warrantsderivativeindirect: See Footnotes
-26,656$2.07$55k8,136,609Dec 6, 2024
Dec 4, 2024Redmile Group, LLC
owner
JOther
Pre-Funded Warrantsderivativeindirect: See Footnotes
+26,656$2.07$55k8,163,265Dec 6, 2024
Dec 4, 2024Redmile Group, LLC
owner
JOther
Pre-Funded Warrantsderivative
+26,656$2.07$55k6,133,837Dec 6, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ADCT insider trading: ADC Therapeutics SA | InsiderTell